United Therapeutics (UTHR) Director Ray Kurzweil Receives Award

What Happened

• Ray Kurzweil, a non-employee director of United Therapeutics Corporation (UTHR), received two grants of restricted stock units (RSUs) on 2026-07-22: 380 RSUs and 1,190 RSUs, for a total of 1,570 RSUs. Each RSU was granted at $0.00 (no cash purchase); the filing reports these as derivative awards (code A).

Key Details

• Transaction date and price: 2026-07-22; price reported $0.00 (award/grant).
• Total awarded: 1,570 RSUs (380 + 1,190).
• Shares owned after transaction: not specified in the provided filing.
• Footnotes of note:
  • F1: Each RSU converts to one share of common stock upon vesting.
  • F2: These are annual non-employee director awards.
  • F3: Vesting occurs on the earlier of (a) one year after the grant or (b) the next Annual Meeting of Shareholders (anticipated June 25, 2027).
  • F4: RSUs have no expiration date.
• Filing timeliness: Report covers transactions on 2026-07-22 and was filed 2026-07-23 (appears timely).

Context

• RSU awards are compensation, not open-market purchases or sales; they do not immediately change share ownership until they vest and are settled. Such director awards are common and typically routine compensation rather than a direct buy or sell signal.